NAD+ (Nicotinamide Adenine Dinucleotide)
Fat LossRedox coenzyme / supplementExperimental
Essential redox cofactor sold as IV clinic infusions and oral precursors (NR/NMN). NAD+ itself is not FDA-approved as a drug for anti-aging.
For research use only.
Key Facts
- CAS
- 53-84-9
- Molecular Weight (MW)
- 663.43 g/mol
- Half-life
- Minutes to hours (rapidly metabolized)
- Unit
- mg
- Administration Route
- IV, IM, Oral
- Frequency
- 1โ3x per week (IV/IM) or daily (oral)
- Last updated
- 8/23/2026
- Targets
- SirtuinsPARPsRedox enzymes
Overview
Essential redox cofactor sold as IV clinic infusions and oral precursors (NR/NMN). NAD+ itself is not FDA-approved as a drug for anti-aging.
Protocol
- Dosage Range
- 100โ1000 mg
- Frequency
- 1โ3x per week (IV/IM) or daily (oral)
- Cycle
- 4โ12 weeks or ongoing for wellness support
- Administration Route
- IV, IM, Oral
- Reconstitution Guide
- Use sterile saline or bacteriostatic water per clinic protocol
Science
Mechanism of Action
Hydride acceptor in dehydrogenase reactions and substrate for sirtuins and PARPs. Direct IV NAD+ pharmacokinetics and anti-aging claims remain under-studied versus oral precursors.
Targets
SirtuinsPARPsRedox enzymes
Studies
- NAD+ metabolism reviewโ Journal/year not available
Benefits
Cellular redox researchClinic IV / precursor supplement use
Potential Side Effects
- IV: chest tightness, nausea, flushing
- Expensive infusions of uncertain benefit
References
- PMID 24786309External link ยท Year โ
- PubChem NAD+External link ยท Year โ